As of 2026-10-05, the Fair Value of 4D Molecular Therapeutics Inc (FDMT) is -17.14 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 13.67 USD, the upside of 4D Molecular Therapeutics Inc is -225.36%.
With the market price of 13.67 USD and our fair value calculation, 4D Molecular Therapeutics Inc (FDMT) is not a good investment. Investing in FDMT stocks now will result in a potential loss of 225.36%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -71.32 | -107.49 | -100.84 | -160.87 | -140.11 | -116.12 |
| YoY growth | -25.81% | -50.72% | 6.19% | -59.53% | 12.90% | -23.39% |
| Market Cap (mil) | 714.67 |
| P/E | |
| Forward P/E |
| EPS | -3.43 |
| Avg earnings growth rate | -23.39% |
| TTM earnings | -179.18 |